Loading...

ALBT AVALON GLOBOCARE CORP US FDA Inspections 8-K Filing

VLN

LBT

AVALON GLOBOCARE CORP

(ALBT)

2025 8-K

Show Summary

Show Summary

Asset Acquisitions

Failure to Meet Requirements

Merger of Equals

Partnership Announcement

Marketing Update

Merger Agreement

Equity Redemption

Patent Approval

Stock Exchange Agreement

Capital Structure Update

Nasdaq Compliance Regained

Marketing Program Launch

Stock Delisting

Management Change

New Development

Stock Split Announcement

Annual Meeting Results

Event Sponsorship

Change in Registrant's Cert...

Convertible Note Financing

Delisting Notice

Delisting Notice

Financial Obligation

Delisting Notice

Convertible Note Financing ...

Annual Meeting Results

New Laboratory Opening

Asset Acquisitions

Strategic Alliances

Sales Agreement with Roth C...

Financing Agreements

Acquisition of Laboratory S...

Appointment of Director

Reverse Stock Split

External Links:

Avalon GloboCare Corp. announced that it received a Notice of Allowance for its patent application AVAR1901CN from the China National Intellectual Property Administration on February 18, 2025.

AI Assistant

AVALON GLOBOCARE CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.